Autres langues COSMOS Pharmaceutical Corporation

Actions

3349

JP3298400007

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
14 700 ^JPY	+0,93%		+1,62%	-9,73%

12/04	Le bénéfice attribuable de Cosmos Pharmaceutical augmente de 6,6 % au cours des neuf premiers mois de l'année fiscale	MT
12/04	COSMOS Pharmaceutical Corporation donne des indications sur le dividende pour l'exercice fiscal se terminant le 31 mai 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	12/04
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	12/04
Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores	12/01
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	12/01
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024	12/01
Criptomonedas: Tres temáticas a tener en cuenta	21/12
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores	12/10/23
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023	11/10/23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	11/10/23
OPINIONES DE LOS ANALISTAS DEL DÍA : Santander, Demant, Lufthansa, AXA, BAE Systems, Adidas, GSK, Demant, Just Eat...	08/08/23
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023	11/07/23
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024	10/07/23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	10/07/23
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings	11/04/23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	10/04/23
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023	10/04/23
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy	16/01/23
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter of Fiscal 2023; Provides Dividend Guidance for the Full Year of Fiscal Year Ending May 31, 2023	13/01/23
Cosmos Pharmaceutical Corporation Provides Earnings Forecast for the Fiscal Year Ending May 31, 2023	13/01/23
Bolsa de Madrid: Japónimación	20/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues COSMOS Pharmaceutical Corporation

Actions

3349

JP3298400007

Autres langues

Filtres